Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03200626 · ClinicalTrials.gov registry record
Observational Study to Evaluate Hematopoietic Progenitor Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma
A clinical trial, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- 750
- Enrollment target
NCT03200626: Completed study, sponsored by Medical College of Wisconsin.
NCT03200626 is a clinical trial that has completed, run by Medical College of Wisconsin. The registered enrollment target is 750 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03200626 has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- 750 participants
- Enrollment target
Study Summary
Prospective, multicenter, observational registry of myeloma patients undergoing hematopoietic progenitor cell mobilization for upfront autologous transplantation.
Primary Outcome
Evaluate efficacy of PBPC mobilization and collection in myeloma patients undergoing cytokine-only vs. chemomobilization vs. plerixafor-based mobilization efficacy parameters including total CD34+ cell yield on the first apheresis (per kg patient weight)
Interventions
- PROCEDURE Autologous hematopoietic cell transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2017-06-01 |
| Est. Completion | 2022-10-31 |
What the finished NCT03200626 record still lists
NCT03200626 is an observational study that tracks outcomes without assigning an intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Autologous hematopoietic cell transplant is the first listed.
NCT03200626 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03200626 about?
NCT03200626 is a clinical study titled "Observational Study to Evaluate Hematopoietic Progenitor Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma". Prospective, multicenter, observational registry of myeloma patients undergoing hematopoietic progenitor cell mobilization for upfront autologous transplantation.
What is the current status of trial NCT03200626?
This trial is currently completed. The enrollment target is 750 participants. The study started on 2017-06-01. Estimated completion is 2022-10-31.
What interventions are being tested in trial NCT03200626?
The interventions under investigation include: Autologous hematopoietic cell transplant (PROCEDURE).
Who is sponsoring clinical trial NCT03200626?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02087852 · 750 participants
Kidney Cancer DNA Registry
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
- NCT03126916 · 750 participants · Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI